跳至主要内容
临床试验/KCT0003744
KCT0003744招募中未知

Ticagrelor monotherapy in PAtients treated with new-generation drug-eluting Stents for acute coronary Syndrome; T-PASS trial

Yonsei University Health System, Severance Hospital0 个研究点目标入组 2,850 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
2,850

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19?(Year) 至 80?(Year)(—)
性别
All

入选标准

  • 1. Patients =19 years old
  • 2. Patients who received new generation sirolimus-eluting (Osiro® series) stent implantation for treating ACS, including acute MI and unstable angina
  • 3. Provision of informed consent

排除标准

  • 1. Age> 80 years
  • 2. Increased risk of bleeding, anemia, thrombocytopenia
  • 3. A need for oral anticoagulation therapy
  • 4. Pregnant women or women with potential childbearing
  • 5. Life expectancy < 1 year

研究者

相似试验